In the first study attempting to formally quantify the deleterious impact of research misconduct on funding sources and publication output, we found that misconduct accounts for a small but substantial portion of American biomedical science funding dollars and damages the productivity and rate of funding acquisition of those who commit misconduct.

Living stock collections provide invaluable resources to research communities, yet they face significant challenges.

A diverse and substantial impact of the COVID-19 pandemic on cancer care is observed, including delays in treatment, screening, and diagnosis, as well as on the psychosocial welling of patients with cancer.

Traveling to conferences with children presents a number of logistical and financial challenges.

An analysis of more than 3000 randomized controlled trials published in JAMA, the Lancet and NEJM has identified 396 medical reversals.

Ending the TB epidemic requires scaling up access to new TB tools so that they can benefit the patients in low- and middle-income countries that need them the most.

Disrupting the right temporo-parietal junction did not change the general motivation to give or adapt behavior to social reputation cues, but specifically reduced the impact of moral-material conflict.

The COVID-19 pandemic has clearly demonstrated the need for a global system to monitor the dynamics of susceptibility and immunity, as well as infection, during epidemics and pandemics.

The National Institutes of Health needs to make radical changes to ensure that biomedical research continues to thrive in the United States.